| 1 |
Collineau B, Genestie C, Croce S, Meeus P, Floquet A, Guyon F, Llacer-Moscardo C, Lebreton C, Taieb S, Toulmonde M, Blay JY, Bonvalot S, Ray-Coquard I, Pautier P, Duffaud F. [Uterine leiomyosarcoma - French guidelines from the GSF/NETSARC and TMRG groups]. Bull Cancer 2023:S0007-4551(23)00050-4. [PMID: 36863922 DOI: 10.1016/j.bulcan.2023.01.009] [Reference Citation Analysis]
|
| 2 |
Smadja J, El Zein S, Pierron G, Watson S, Laas E, Ramtohul T, Tzanis D, Servois V, Bonvalot S. Percutaneous Uterine Needle Biopsy with Microscopic and Array-CGH Analyses for Preoperative Sarcoma Diagnosis in Patients with Suspicious Myometrial Tumors on MRI: A Prospective Pilot Study (SARCGYN). Ann Surg Oncol 2023;30:943-53. [PMID: 36287348 DOI: 10.1245/s10434-022-12697-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Hinchcliff E, Lawson B, Fleming ND. Other rare uterine sarcomas: Adenosarcoma, endometrial stromal sarcoma, STUMP. Diagnosis and Treatment of Rare Gynecologic Cancers 2023. [DOI: 10.1016/b978-0-323-82938-0.00010-0] [Reference Citation Analysis]
|
| 4 |
Hariprasad CP, Kumar A, Rohit G, Surabhi S, Bhatt D. Primary Retroperitoneal Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Diagnostic Enigma. Cureus 2023;15:e33332. [PMID: 36751185 DOI: 10.7759/cureus.33332] [Reference Citation Analysis]
|
| 5 |
Vimercati A, Santarsiero CM, Esposito A, Putino C, Malvasi A, Damiani GR, Laganà AS, Vitagliano A, Marinaccio M, Resta L, Cicinelli E, Cazzato G, Cascardi E, Dellino M. An Extremely Rare Case of Disseminated Peritoneal Leiomyomatosis with a Pelvic Leiomyosarcoma and Omental Metastasis after Laparoscopic Morcellation: Systematic Review of the Literature. Diagnostics (Basel) 2022;12. [PMID: 36553227 DOI: 10.3390/diagnostics12123219] [Reference Citation Analysis]
|
| 6 |
Liu H, Wong C, Wong C, Liu F. Uterine smooth muscle tumor of uncertain malignant potential: A review of current knowledge. Taiwanese Journal of Obstetrics and Gynecology 2022;61:935-940. [DOI: 10.1016/j.tjog.2022.08.003] [Reference Citation Analysis]
|
| 7 |
Croce S, Devouassoux-Shisheboran M, Pautier P, Ray-Coquard I, Treilleux I, Neuville A, Arnould L, Just PA, Belda MALF, Averous G, Leroux A, Mery E, Loussouarn D, Weinbreck N, Le Guellec S, Mishellany F, Morice P, Guyon F, Genestie C. Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group. Gynecol Oncol 2022:S0090-8258(22)00515-7. [PMID: 36114030 DOI: 10.1016/j.ygyno.2022.07.031] [Reference Citation Analysis]
|
| 8 |
Borella F, Cosma S, Ferraioli D, Ray-Coquard I, Chopin N, Meeus P, Cockenpot V, Valabrerga G, Scotto G, Turinetto M, Biglia N, Fuso L, Mariani L, Franchi D, Vidal Urbinati AM, Pino I, Bertschy G, Preti M, Benedetto C, Castellano I, Cassoni P, Bertero L. Clinical and Histopathological Predictors of Recurrence in Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Multicenter Retrospective Cohort Study of Tertiary Centers. Ann Surg Oncol 2022. [PMID: 35976464 DOI: 10.1245/s10434-022-12353-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Frezza AM, Stacchiotti S, Chibon F, Coindre JM, Italiano A, Romagnosa C, Bagué S, Dei Tos AP, Braglia L, Palmerini E, Quagliuolo V, Broto JM, Lopez Pousa A, Grignani G, Brunello A, Blay JY, Beveridge RD, Lugowska I, Lesluyes T, Maestro R, Merlo FD, Casali PG, Gronchi A. CINSARC in high-risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG-STS 1001 study. Cancer Med 2023;12:1350-7. [PMID: 35848358 DOI: 10.1002/cam4.5015] [Reference Citation Analysis]
|
| 10 |
Chiang S. Mesenchymal Tumors, Pathology of the Uterine Corpus. Encyclopedia of Pathology 2022. [DOI: 10.1007/978-3-319-28845-1_5626-1] [Reference Citation Analysis]
|
| 11 |
Travaglino A, Raffone A, Gencarelli A, Neola D, Oliviero DA, Alfano R, Campanino MR, Cariati F, Zullo F, Mollo A, Insabato L. p53, p16 and ki67 as immunohistochemical prognostic markers in uterine smooth muscle tumors of uncertain malignant potential (STUMP). Pathol Res Pract 2021;226:153592. [PMID: 34481212 DOI: 10.1016/j.prp.2021.153592] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Zhang C, Gao J, Lu S, Zhang Y, Zhu H. Uterine smooth muscle tumors of uncertain malignant potential (STUMP): A retrospective study in a single center. Eur J Obstet Gynecol Reprod Biol 2021;265:74-9. [PMID: 34467879 DOI: 10.1016/j.ejogrb.2021.08.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 13 |
Olga T, Stavroula Lila K, Kounidas G, Maria P, Nikolaos V. Uterine smooth muscle tumour of uncertain malignant potential and in vitro fertilization treatment in an infertile patient. SAGE Open Med Case Rep 2021;9:2050313X211012516. [PMID: 33996092 DOI: 10.1177/2050313X211012516] [Reference Citation Analysis]
|
| 14 |
Keyhanian K, Lage JM, Chernetsova E, Sekhon H, Eslami Z, Islam S. Combination of MCM2 With Ki67 and p16 Immunohistochemistry Can Distinguish Uterine Leiomyosarcomas. Int J Gynecol Pathol 2020;39:354-61. [PMID: 32515921 DOI: 10.1097/PGP.0000000000000616] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 15 |
Conconi D, Redaelli S, Lissoni AA, Cilibrasi C, Perego P, Gautiero E, Sala E, Paderno M, Dalprà L, Landoni F, Lavitrano M, Roversi G, Bentivegna A. Genomic and Epigenomic Profile of Uterine Smooth Muscle Tumors of Uncertain Malignant Potential (STUMPs) Revealed Similarities and Differences with Leiomyomas and Leiomyosarcomas. Int J Mol Sci 2021;22:1580. [PMID: 33557274 DOI: 10.3390/ijms22041580] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 16 |
Terasaki M, Terasaki Y, Wakamatsu K, Kuwahara N, Yoneyama K, Kawase R, Kurose K, Toda E, Endo Y, Kunugi S, Kajimoto Y, Shimizu A. Uterine leiomyosarcomas with osteoclast-like giant cells associated with high expression of RUNX2 and RANKL. Virchows Arch 2021;478:893-904. [PMID: 33404854 DOI: 10.1007/s00428-020-02996-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 17 |
Bennett JA, Oliva E. Undifferentiated and dedifferentiated neoplasms of the female genital tract. Semin Diagn Pathol 2020:S0740-2570(20)30099-X. [PMID: 33323288 DOI: 10.1053/j.semdp.2020.11.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 18 |
Croce S, Chibon F. Molecular prognostication of uterine smooth muscle neoplasms: From CGH array to CINSARC signature and beyond. Genes Chromosomes Cancer 2021;60:129-37. [PMID: 33099852 DOI: 10.1002/gcc.22906] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 19 |
Ordulu Z, Chai H, Peng G, McDonald AG, De Nictolis M, Garcia-Fernandez E, Hardisson D, Prat J, Li P, Hui P, Oliva E, Buza N. Molecular and clinicopathologic characterization of intravenous leiomyomatosis. Mod Pathol 2020;33:1844-60. [PMID: 32341498 DOI: 10.1038/s41379-020-0546-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 20 |
Alpert L, Al-Sabti R, Graham RP, Pai RK, Gonzalez RS, Zhang X, Smith V, Wang HL, Westbrook L, Goldblum JR, Bakhshwin A, Shetty S, Klimstra DS, Shia J, Askan G, Robert ME, Thomas C, Frankel WL, Alsomali M, Hagen C, Mostafa ME, Feely MM, Assarzadegan N, Misdraji J, Shih AR, Agostini-Vulaj D, Meis JM, Tang S, Chatterjee D, Kang LI, Hart J, Lee SM, Smith T, Yantiss RK, Hissong EM, Gao ZH, Wu J, Resnick MB, Wu EY, Pai RK, Zhao L, Doyle LA, Chopra S, Panarelli NC, Hu S, Longacre TA, Raghavan SS, Lauwers GY, Ghayouri M, Cooper HS, Nagarathinam R, Bellizzi AM, Kakar S, Hosseini M, Rong J, Greenson JK, Lamps LW, Dong Z, Bronner MP. Smooth muscle tumors of the gastrointestinal tract: an analysis of prognostic features in 407 cases. Mod Pathol 2020;33:1410-9. [PMID: 32051556 DOI: 10.1038/s41379-020-0492-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 21 |
Cotrino I, Carosso A, Macchi C, Baima Poma C, Cosma S, Ribotta M, Viora E, Sciarrone A, Borella F, Zola P. Ultrasound and clinical characteristics of uterine smooth muscle tumors of uncertain malignant potential (STUMPs). Eur J Obstet Gynecol Reprod Biol 2020;251:167-72. [PMID: 32505056 DOI: 10.1016/j.ejogrb.2020.05.040] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 22 |
Holzmann C, Kuepker W, Rommel B, Helmke B, Bullerdiek J. Reasons to Reconsider Risk Associated With Power Morcellation of Uterine Fibroids. In Vivo 2020;34:1-9. [PMID: 31882457 DOI: 10.21873/invivo.11739] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 23 |
Ganesan R. Uterine smooth muscle tumour of uncertain malignant potential (STUMP): Where are we now? Case Rep Womens Health 2020;26:e00176. [PMID: 32055453 DOI: 10.1016/j.crwh.2020.e00176] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 24 |
Shim JI, Han AKW, Jeon HJ, Kim ML, Jung YW, Yun BS, Seong SJ, Shin E, Cho YJ, Rha SH. Clinical experience of uterine smooth muscle tumor of uncertain malignant potential in two gynecological centers: Oncological and obstetrical aspects. Eur J Obstet Gynecol Reprod Biol 2020;246:7-13. [PMID: 31927240 DOI: 10.1016/j.ejogrb.2020.01.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 25 |
Mccluggage WG. Immunohistochemistry and Molecular Diagnostics in the Differential Diagnosis of Female Genital Tract Pathology. Gynecologic Pathology 2020. [DOI: 10.1016/b978-0-323-35909-2.00020-5] [Reference Citation Analysis]
|
| 26 |
Parra-herran C. Mesenchymal and Miscellaneous Lesions of the Uterus. Gynecologic Pathology 2020. [DOI: 10.1016/b978-0-323-35909-2.00011-4] [Reference Citation Analysis]
|
| 27 |
Devereaux KA, Schoolmeester JK. Smooth Muscle Tumors of the Female Genital Tract. Surg Pathol Clin 2019;12:397-455. [PMID: 31097110 DOI: 10.1016/j.path.2019.02.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 28 |
Yoon JY, Mariño-Enriquez A, Stickle N, de Borja RJ, Ismiil N, Djordjevic B, Virtanen C, Ravat A, Nucci MR, Mirkovic J, Parra-Herran C. Myxoid smooth muscle neoplasia of the uterus: comprehensive analysis by next-generation sequencing and nucleic acid hybridization. Mod Pathol 2019;32:1688-97. [PMID: 31189997 DOI: 10.1038/s41379-019-0299-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 29 |
Karataşlı V, Çakır İ, Ayaz D, Budak A, Sancı M. Clinicopathologic evaluation of uterine smooth muscle tumors of uncertain malignant potential (STUMP): A single center experience. Journal of Gynecology Obstetrics and Human Reproduction 2019;48:637-42. [DOI: 10.1016/j.jogoh.2019.03.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 30 |
Bizzarri N, Ghirardi V, Di Fiore GLM, De Iaco P, Gadducci A, Casarin J, Perrone AM, Pasciuto T, Scambia G, Fagotti A. Secondary cytoreductive surgery in recurrent uterine leiomyosarcoma: a multi-institutional study. Int J Gynecol Cancer 2019;29:1134-40. [PMID: 31420411 DOI: 10.1136/ijgc-2019-000355] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 31 |
Lax SF. [Mesenchymal and mixed uterine tumors : Current overview and practical aspects]. Pathologe 2019;40:36-45. [PMID: 30694356 DOI: 10.1007/s00292-019-0567-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 32 |
Gadducci A, Zannoni GF. Uterine smooth muscle tumors of unknown malignant potential: A challenging question. Gynecol Oncol 2019;154:631-7. [PMID: 31326137 DOI: 10.1016/j.ygyno.2019.07.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 33 |
Rubisz P, Ciebiera M, Hirnle L, Zgliczyńska M, Łoziński T, Dzięgiel P, Kobierzycki C. The Usefulness of Immunohistochemistry in the Differential Diagnosis of Lesions Originating from the Myometrium. Int J Mol Sci 2019;20:E1136. [PMID: 30845657 DOI: 10.3390/ijms20051136] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 34 |
Şahin H, Karatas F, Coban G, Özen Ö, Erdem Ö, Onan MA, Ayhan A. Uterine smooth muscle tumor of uncertain malignant potential: fertility and clinical outcomes. J Gynecol Oncol 2019;30:e54. [PMID: 31074239 DOI: 10.3802/jgo.2019.30.e54] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 35 |
Ptáková N, Miesbauerová M, Kosťun J, Grossmann P, Šidlová H, Pavelka J, Presl J, Alaghehbandan R, Bouda J, Ondič O. Immunohistochemical and selected genetic reflex testing of all uterine leiomyosarcomas and STUMPs for ALK gene rearrangement may provide an effective screening tool in identifying uterine ALK-rearranged mesenchymal tumors. Virchows Arch 2018;473:583-90. [DOI: 10.1007/s00428-018-2428-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
|
